Y-mAbs Therapeutics, Inc. Operating Cash Flow
Y-mAbs Therapeutics, Inc. reported Operating Cash Flow of -$5.26 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-08-08
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was $1.65M, a 454.03% increase year-over-year.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$6.91M.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$1.87M.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$10.66M.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$15.71M.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$27.23M.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$75.92M.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$102.56M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$5.26M 10-Q · filed 2025-08-08 | -$7.13M derived: sum of 3 quarters · filed 2025-08-08 | -$17.80M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$6.91M 10-Q · filed 2025-05-13 | -$8.78M derived: sum of 2 quarters · filed 2025-05-13 | -$19.45M derived: sum of 3 quarters · filed 2025-05-13 | -$19.15M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$12.54M derived: sum of 2 quarters · filed 2025-03-04 | -$12.24M derived: sum of 3 quarters · filed 2025-08-08 | -$15.71M 10-K · filed 2025-03-04 |
| 2024-09-30 | -$10.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$10.37M derived: sum of 2 quarters · filed 2025-08-08 | -$13.84M 10-Q · filed 2024-11-08 | -$21.88M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$3.18M 10-Q · filed 2025-08-08 | -$11.21M derived: sum of 3 quarters · filed 2025-08-08 | -$12.55M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$3.48M 10-Q · filed 2025-05-13 | -$11.51M derived: sum of 2 quarters · filed 2025-05-13 | -$12.85M derived: sum of 3 quarters · filed 2025-05-13 | -$17.59M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$8.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$9.37M derived: sum of 2 quarters · filed 2025-03-04 | -$14.11M derived: sum of 3 quarters · filed 2025-03-04 | -$27.23M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$6.07M derived: sum of 2 quarters · filed 2024-11-08 | -$19.20M 10-Q · filed 2024-11-08 | -$27.86M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$4.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$17.86M 10-Q · filed 2024-08-12 | -$26.52M derived: sum of 3 quarters · filed 2024-08-12 | -$45.75M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$13.12M 10-Q · filed 2024-05-07 | -$21.79M derived: sum of 2 quarters · filed 2024-05-07 | -$41.02M derived: sum of 3 quarters · filed 2024-05-07 | -$64.12M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$27.90M derived: sum of 2 quarters · filed 2024-02-29 | -$51.00M derived: sum of 3 quarters · filed 2024-02-29 | -$75.92M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$19.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$42.34M derived: sum of 2 quarters · filed 2023-11-13 | -$67.26M 10-Q · filed 2023-11-13 | -$101.12M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$23.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$48.02M 10-Q · filed 2023-08-10 | -$81.89M derived: sum of 3 quarters · filed 2023-08-10 | -$99.96M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$24.93M 10-Q · filed 2023-05-08 | -$58.79M derived: sum of 2 quarters · filed 2023-05-08 | -$76.86M derived: sum of 3 quarters · filed 2023-05-08 | -$95.62M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$33.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$51.94M derived: sum of 2 quarters · filed 2023-03-30 | -$70.69M derived: sum of 3 quarters · filed 2023-03-30 | -$102.56M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$18.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$36.83M derived: sum of 2 quarters · filed 2022-11-07 | -$68.69M 10-Q · filed 2022-11-07 | -$86.39M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$18.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$50.62M 10-Q · filed 2022-08-08 | -$68.31M derived: sum of 3 quarters · filed 2022-08-08 | -$92.46M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$31.86M 10-Q · filed 2022-05-09 | -$49.56M derived: sum of 2 quarters · filed 2022-05-09 | -$73.70M derived: sum of 3 quarters · filed 2022-05-09 | -$101.34M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$41.84M derived: sum of 2 quarters · filed 2022-03-01 | -$69.47M derived: sum of 3 quarters · filed 2022-03-01 | -$91.23M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$24.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$51.78M derived: sum of 2 quarters · filed 2021-11-04 | -$73.54M 10-Q · filed 2021-11-04 | -$98.11M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$27.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$49.39M 10-Q · filed 2021-08-09 | -$73.97M derived: sum of 3 quarters · filed 2022-03-01 | -$95.36M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$21.76M 10-Q · filed 2021-05-06 | -$46.34M derived: sum of 2 quarters · filed 2022-03-01 | -$67.73M derived: sum of 3 quarters · filed 2022-03-01 | -$81.77M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$24.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$45.97M derived: sum of 2 quarters · filed 2022-03-01 | -$60.01M derived: sum of 3 quarters · filed 2022-03-01 | -$73.50M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$21.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$35.44M derived: sum of 2 quarters · filed 2020-11-05 | -$48.92M 10-Q · filed 2020-11-05 | -$62.49M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$14.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$27.52M 10-Q · filed 2020-08-06 | -$41.10M derived: sum of 3 quarters · filed 2020-08-06 | -$50.29M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$13.48M 10-Q · filed 2020-05-07 | -$27.06M derived: sum of 2 quarters · filed 2020-05-07 | -$36.25M derived: sum of 3 quarters · filed 2020-05-07 | -$48.10M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$13.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$22.77M derived: sum of 2 quarters · filed 2020-03-12 | -$34.62M derived: sum of 3 quarters · filed 2020-03-12 | -$41.23M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$9.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$21.04M derived: sum of 2 quarters · filed 2019-11-13 | -$27.65M 10-Q · filed 2019-11-13 | -$33.96M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | -$11.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$18.46M 10-Q · filed 2019-08-14 | -$24.77M derived: sum of 3 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$6.61M 10-Q · filed 2019-05-10 | -$12.92M derived: sum of 2 quarters · filed 2019-05-10 | ||
| 2017-12-31 | -$6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$15.87M 10-K · filed 2019-03-22 | ||
| 2017-09-30 | -$9.56M 10-Q · filed 2018-11-13 |